恒瑞医药(01276.HK)9月11日耗资1592.7万元回购23.5万股A股

Group 1 - The company, Heng Rui Pharmaceutical, announced a share buyback plan on September 11, 2025, involving an expenditure of RMB 15.927 million to repurchase 235,000 A-shares [1] - The repurchase price per share is set between RMB 67.20 and RMB 68.41 [1]